Xtant Medical Holdings, Inc. (XTNT) — 分析摘要
Xtant Medical Holdings, Inc.（XTNT）的市值为60.29百万美元，最近一年的营收同比增长了+14.2%。净利润率为3.7%。当前市盈率为33.0倍。
核心要点
- 营收同比变化+14.2%
- 净利润率3.7%
- 市盈率33.0倍
与SURGICAL & MEDICAL INSTRUMENTS & APPARATUS板块的其他公司相比，XTNT的营收增长为+14.2%，市盈率为33.0倍。
Xtant Medical Holdings, Inc. (XTNT)
更新 — ET · 来源 POLYGON
红旗与风险提示高风险信号
存在多项实质性红旗，在依赖任何估值输出前应先重点核查这些风险。
利息保障倍数为 1.0x — 偿债缓冲极低
净利润较上一期下降 63.3%。
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
行业
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
员工人数
151
总部
BELGRADE, MT
Exchange
XASE
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。